IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
Recruiting now · Phase 1
Conditions studied: Glioblastoma Multiforme, Glioblastoma
In brief
This is a phase I study to assess the safety and feasibility of IL-8 receptor modified patient-derived activated CD70 CAR T cell therapy in CD70+ adult glioblastoma
Key facts
- Study ID
- NCT05353530
- Run by
- University of Florida
- People needed
- 39
- Starts
- 2023-07-25
- Expected to finish
- 2042-12-01
- Last updated by the study team
- 2026-05-27
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Florida Health — Gainesville, Florida, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.